Provider’s Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer
Abstract
:1. Introduction
2. Methods
2.1. Participants and Procedures
2.2. Interview Guide
2.3. Qualitative Analysis
3. Results
3.1. Perceived Facilitators to Participate in GCRA
“I think family is really at the forefront of a lot of the decision making for Latina women. Family, that is the first thing that is brought up (…) they have more of a collective mentality”—Genetic counselor
“If they are already diagnosed with cancer [women seek genetic testing] to know whether or not they should have done a bilateral mastectomy”—Navigator
“People are sent because their doctors go “you are 35 and you need to go to genetic counseling” and you get people who come here and go “I’m here because my doctor told me I had to, but I don’t know”—Genetic counselor
3.2. Perceived Barriers to Participate in GCRA
“The cost can be prohibitive…I don’t know what percentage insurance covers genetic testing”—Navigator
“The other problem is the payment, people think that the insurance will not cover it and they are convinced that they will have to pay for it when in reality, for most people, insurance will cover it”—Geneticist
“Most laboratories have testing hardship program[s], so if someone is low income and we can get them free testing setup, that is actually quite easy, but it is kind of ironic that the genetic counseling part can sometimes be a lot harder to get because there aren’t that many free resources for genetic counseling”—Genetic counselor
“The providers may not always guarantee that the testing will be covered. A lot of my patients are told that it’s not going to be covered when it actually is, so they are never referred to start”—Genetic counselor
“These are all staged breast cancer patients who have already been identified as breast cancer patients and they had been recommended for testing and counseling. Sometimes they get the testing but they won’t get the counseling (because extra cost)”—Navigator
“A lot of people work full time and have a lot of problems getting to the appointments during business hours, or have jobs where they can’t leave work or they would have to take time off, they can’t afford the day off or they employer won’t let them take the day off”—Genetic counselor
“Some people are not ready in that moment and prefer to wait, especially if they had a negative experience with a relative, so there is people that say I will die of something so I prefer not to know”—Navigator
“I remember one patient in particular from Bolivia and she felt much safer being here and talking about it with people. She said that if she were to bring this up back home that people would be doing a lot of gossiping and that it would be malicious and hurtful and it would be detrimental to her in various ways”—Psychologist/counselor
“Sometimes, in a few instances, some people are afraid to fill out paperwork for the free testing because they were undocumented. But I would have said this is fairly rare.”—GC
3.3. Genetic Counselors’ Experiences during Counseling
“(The sessions with interpreters are) about a third longer because you have to repeat everything twice (…) a lot of what we do is try to build rapport with the patient and that’s just an added layer. I have had good sessions with interpreters but it does make it a little more difficult if a patient is more engaged with the interpreter, they [the patients] are looking at the telephone, and it’s hard to make the contact with them. These [are] little things and nuances in a session but overall might really affect the communication.”—Genetic counselor
“That’s a question I get a lot. “You know, well, in a few years if you did this test again, could I get back something different?”—Genetic counselor
“One of the major misconceptions is that these breast cancer genes can only come from the mom’s side of the family (…) So that is something that comes as a shock to a lot of people, especially when you’re doing the family history right in front of them (…) and you start to point out things in the dad’s side of the family”—Genetic counselor
“I want my patients to see that information as a gift they provide to their kids. The perception is ‘Oh, I am causing cancer to my kids.’ I try to change that perception to ‘this is random (…) try to see this as a present to your daughter or son, you are giving them the possibility of being proactive instead of reactive in their healthcare’”.—Genetic counselor
“There is like this hole certainly in the past, you know, this old taboo that people don’t talk about cancer. And so we did not know what happened to grandma, so and so, or grandpa, so and so, or uncle so and so or whoever was, they just got sick and then they died and we really don’t know what happened”—Genetic counselor
“I usually pass it along to my patient and hope that they pass it on to their relative. But yeah, it can be difficult and frustrating because either from just the location or just the relatives not communicating well, it’s hard to get information to the family”—Genetic counselor
“Something that is more unique to the Latina population I see, at least compared to other of my patients, a lot of their relatives are not here in the United States. So that brings up questions if I have this information will that benefit my relatives? Will they be able to get tested? Will they be able to get the screening they need or will they be able to get the information they need?”—Genetic counselor
“Sometimes it’s just really hard for me to get back in touch with the patient. Sometimes their phone numbers won’t work or they’ll have voicemail and I’ll call with the translator and I’ll call and leave a message but I don’t know if they’ve checked their message, there is just those like logistical things.”—Genetic counselor
“I feel like maybe there are fewer questions. And so sometimes I wonder, “is it something getting lost in translation? Do they not feel comfortable?” It’s hard because you want to make sure that everyone has the information to make an informed decision. But there is very little push back (…)”—Genetic counselor
“When we ask them ‘would you like to do the test or not?’ the patients are confused and tell me ‘well, you are the health professional, you should decide whether I do the test or not.’ (…). We try to be a little more directive and tell them ‘In my professional opinion I recommend this test (…) but ultimately the decision is yours.’”—Genetic counselor
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Easton, D.F. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1999, 1, 14–17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, S.; Parmigiani, G. Meta-analysis of BRCA1 and BRCA2 penetrance. J. Clin. Oncol. 2007, 25, 1329–1333. [Google Scholar] [CrossRef] [PubMed]
- Valachis, A.; Nearchou, A.D.; Lind, P. Surgical management of breast cancer in BRCA-mutation carriers: A systematic review and meta-analysis. Breast Cancer Res. Treat. 2014, 144, 443–455. [Google Scholar] [CrossRef] [PubMed]
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian. Available online: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#detection (accessed on 15 June 2015).
- Weitzel, J.N.; McCaffrey, S.M.; Nedelcu, R.; MacDonald, D.J.; Blazer, K.R.; Cullinane, C.A. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch. Surg. 2003, 138, 1323–1328. [Google Scholar] [CrossRef] [PubMed]
- Schwartz, M.D.; Isaacs, C.; Graves, K.D.; Poggi, E.; Peshkin, B.N.; Gell, C.; Finch, C.; Kelly, S.; Taylor, K.L.; Perley, L. Long-term outcomes of BRCA1/BRCA2 testing: Risk reduction and surveillance. Cancer 2012, 118, 510–517. [Google Scholar] [CrossRef] [PubMed]
- Herrinton, L.J.; Barlow, W.E.; Yu, O.; Geiger, A.M.; Elmore, J.G.; Barton, M.B.; Harris, E.L.; Rolnick, S.; Pardee, R.; Husson, G. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: A cancer research network project. J. Clin. Oncol. 2005, 23, 4275–4286. [Google Scholar] [CrossRef] [PubMed]
- McDonnell, S.K.; Schaid, D.J.; Myers, J.L.; Grant, C.S.; Donohue, J.H.; Woods, J.E.; Frost, M.H.; Johnson, J.L.; Sitta, D.L.; Slezak, J.M. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J. Clin. Oncol. 2001, 19, 3938–3943. [Google Scholar] [CrossRef] [PubMed]
- Van Sprundel, T.C.; Schmidt, M.K.; Rookus, M.A.; Brohet, R.; Van Asperen, C.J.; Rutgers, E.T.; van’t Veer, L.J.; Tollenaar, R. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br. J. Cancer 2005, 93, 287–292. [Google Scholar] [CrossRef] [PubMed]
- Kauff, N.D.; Satagopan, J.M.; Robson, M.E.; Scheuer, L.; Hensley, M.; Hudis, C.A.; Ellis, N.A.; Boyd, J.; Borgen, P.I.; Barakat, R.R. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 2002, 346, 1609–1615. [Google Scholar] [CrossRef] [PubMed]
- Rebbeck, T.R.; Lynch, H.T.; Neuhausen, S.L.; Narod, S.A.; Van’t Veer, L.; Garber, J.E.; Evans, G.; Isaacs, C.; Daly, M.B.; Matloff, E. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 2002, 346, 1616–1622. [Google Scholar] [CrossRef] [PubMed]
- Salhab, M.; Bismohun, S.; Mokbel, K. Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery. BMC Womens Health 2010, 10, 28. [Google Scholar] [CrossRef] [PubMed]
- Robson, M.; Im, S.; Senkus, E.; Xu, B.; Domchek, S.M.; Masuda, N.; Delaloge, S.; Li, W.; Tung, N.; Armstrong, A. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N. Engl. J. Med. 2017, 377, 523–533. [Google Scholar] [CrossRef] [PubMed]
- Kaufman, B.; Shapira-Frommer, R.; Schmutzler, R.K.; Audeh, M.W.; Friedlander, M.; Balmaña, J.; Mitchell, G.; Fried, G.; Stemmer, S.M.; Hubert, A. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J. Clin. Oncol. 2014, 33, 244–250. [Google Scholar] [CrossRef] [PubMed]
- Weitzel, J.N.; Clague, J.; Martir-Negron, A.; Ogaz, R.; Herzog, J.; Ricker, C.; Jungbluth, C.; Cina, C.; Duncan, P.; Unzeitig, G. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: A report from the Clinical Cancer Genetics Community Research Network. J. Clin. Oncol. 2013, 31, 210. [Google Scholar] [CrossRef] [PubMed]
- Dutil, J.; Golubeva, V.A.; Pacheco-Torres, A.L.; Diaz-Zabala, H.J.; Matta, J.L.; Monteiro, A.N. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: A clinical perspective. Breast Cancer Res. Treat. 2015, 154, 441–453. [Google Scholar] [CrossRef] [PubMed]
- National Human Genome Research Institute ELSI Research Priorities and Possible Research Topics. Available online: http://www.genome.gov/27543732 (accessed on 20 February 2014).
- Mai, P.L.; Vadaparampil, S.T.; Breen, N.; McNeel, T.S.; Wideroff, L.; Graubard, B.I. Awareness of cancer susceptibility genetic testing: The 2000, 2005, and 2010 National Health Interview Surveys. Am. J. Prev. Med. 2014, 46, 440–448. [Google Scholar] [CrossRef] [PubMed]
- Donovan, K.A.; Tucker, D.C. Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a sociodemographically diverse sample. J. Behav. Med. 2000, 23, 15–36. [Google Scholar] [CrossRef] [PubMed]
- Gammon, A.D.; Rothwell, E.; Simmons, R.; Lowery, J.T.; Ballinger, L.; Hill, D.A.; Boucher, K.M.; Kinney, A.Y. Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer. J. Genet. Couns. 2011, 20, 625–638. [Google Scholar] [CrossRef] [PubMed]
- Hughes, C.; Gomez-Caminero, A.; Benkendorf, J.; Kerner, J.; Isaacs, C.; Barter, J.; Lerman, C. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ. Couns. 1997, 32, 51–62. [Google Scholar] [CrossRef]
- Kutner, M.; Greenburg, E.; Jin, Y.; Paulsen, C. The Health Literacy of America’s Adults: Results from the 2003 National Assessment of Adult Literacy. NCES 2006-483; National Center for Education Statistics: Washington, DC, USA, 2006.
- National Center for Education Statistics. National Assessment of Adult Literacy (NAAL). A First Look at the Literacy of America’s Adults in the 21st Century; U.S. Department of Education: Washington, DC, USA, 2006; Volume NCES 2006-470.
- Dean, M.; Boland, J.; Yeager, M.; Im, K.M.; Garland, L.; Rodriguez-Herrera, M.; Perez, M.; Mitchell, J.; Roberson, D.; Jones, K. Addressing health disparities in Hispanic breast cancer: Accurate and inexpensive sequencing of BRCA1 and BRCA2. Gigascience 2015, 4, 50. [Google Scholar] [CrossRef] [PubMed]
- Levy, D.E.; Byfield, S.D.; Comstock, C.B.; Garber, J.E.; Syngal, S.; Crown, W.H.; Shields, A.E. Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk. Genet. Med. 2011, 13, 349. [Google Scholar] [CrossRef] [PubMed]
- Kinney, A.Y.; Gammon, A.; Coxworth, J.; Simonsen, S.E.; Arce-Laretta, M. Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet. Med. 2010, 12, 105–115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mays, D.; Sharff, M.E.; DeMarco, T.A.; Williams, B.; Beck, B.; Sheppard, V.B.; Peshkin, B.N.; Eng-Wong, J.; Tercyak, K.P. Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women. Fam. Cancer 2012, 11, 493–502. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sussner, K.M.; Jandorf, L.; Thompson, H.S.; Valdimarsdottir, H.B. Interest and beliefs about BRCA genetic counseling among at-risk Latinas in New York City. J. Genet. Couns. 2010, 19, 255–268. [Google Scholar] [CrossRef] [PubMed]
- Sussner, K.M.; Jandorf, L.; Thompson, H.S.; Valdimarsdottir, H.B. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City. PsychoOncology 2013, 22, 1594–1604. [Google Scholar] [CrossRef] [PubMed]
- Vadaparampil, S.T.; Wideroff, L.; Breen, N.; Trapido, E. The impact of acculturation on awareness of genetic testing for increased cancer risk among Hispanics in the year 2000 National Health Interview Survey. Cancer Epidemiol. Prev. Biomarkers 2006, 15, 618–623. [Google Scholar] [CrossRef] [PubMed]
- Pagan, J.A.; Su, D.; Li, L.; Armstrong, K.; Asch, D.A. Racial and ethnic disparities in awareness of genetic testing for cancer risk. Am. J. Prev. Med. 2009, 37, 524–530. [Google Scholar] [CrossRef] [PubMed]
- Jagsi, R.; Griffith, K.A.; Kurian, A.W.; Morrow, M.; Hamilton, A.S.; Graff, J.J.; Katz, S.J.; Hawley, S.T. Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. J. Clin. Oncol. 2015, 33, 1584. [Google Scholar] [CrossRef] [PubMed]
- Thompson, H.S.; Sussner, K.; Schwartz, M.D.; Edwards, T.; Forman, A.; Jandorf, L.; Brown, K.; Bovbjerg, D.H.; Valdimarsdottir, H.B. Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations. Genet. Test. Mol. Biomarkers 2012, 16, 1257–1262. [Google Scholar] [CrossRef] [PubMed]
- Ricker, C.; Lagos, V.; Feldman, N.; Hiyama, S.; Fuentes, S.; Kumar, V.; Gonzalez, K.; Palomares, M.; Blazer, K.; Lowstuter, K.; et al. If We Build It … Will They Come?—Establishing a Cancer Genetics Services Clinic for an Underserved Predominantly Latina Cohort. J. Genet. Couns. 2006, 15, 505–514. [Google Scholar] [CrossRef] [PubMed]
- Pasick, R.J.; Joseph, G.; Stewart, S.; Kaplan, C.; Lee, R.; Luce, J.; Davis, S.; Marquez, T.; Nguyen, T.; Guerra, C. Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial. Am. J. Public Health 2016, 106, 1842–1848. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Augusto, B.; Kasting, M.L.; Couch, F.J.; Lindor, N.M.; Vadaparampil, S.T. Current Approaches to Cancer Genetic Counseling Services for Spanish-Speaking Patients. J. Immigr. Minor. Health 2018, 20, 1–4. [Google Scholar] [CrossRef] [PubMed]
- Joseph, G.; Pasick, R.; Schillinger, D.; Luce, J.; Guerra, C.; Cheng, J. Information Mismatch: Cancer Risk Counseling with Diverse Underserved Patients. J. Genet. Couns. 2017, 26, 1090–1104. Available online: https://search.proquest.com/docview/1938855633 (accessed on 13 May 2018). [CrossRef] [PubMed]
- Joseph, G.; Guerra, C. To worry or not to worry: Breast cancer genetic counseling communication with low-income Latina immigrants. J. Community Genet. 2015, 6, 63–76. [Google Scholar] [CrossRef] [PubMed]
- Kamara, D.; Weil, J.; Youngblom, J.; Guerra, C.; Joseph, G. Cancer Counseling of Low-Income Limited English Proficient Latina Women Using Medical Interpreters: Implications for Shared Decision-Making. J. Genet. Couns. 2018, 27, 155–168. Available online: https://link.springer.com/article/10.1007/s10897-017-0132-5 (accessed on 20 June 2018). [CrossRef] [PubMed]
- Hill, C.E.; Knox, S.; Thompson, B.J.; Williams, E.N.; Hess, S.A.; Ladany, N. Consensual Qualitative Research. J. Couns. Psychol. 2005, 52, 196–205. [Google Scholar] [CrossRef]
- SocioCultural Research Consultants, LLC. Dedoose Version 7.0.23, Web Application for Managing, Analyzing, and Presenting Qualitative and Mixed Method Research Data; SocioCultural Research Consultants, LLC: Los Angeles, CA, USA, 2016. [Google Scholar]
- Lara-Otero, K. Attitudes towards Interpretation Services Provided to Underserved Patients during Cancer Genetic Counseling Sessions in the Public Hospital Setting: Perspectives from Genetic Counselors and Interpreters. Ph.D. Thesis, California State University, Stanislaus, CA, USA, 2016. [Google Scholar]
- Sussner, K.M.; Edwards, T.; Villagra, C.; Rodriguez, M.C.; Thompson, H.S.; Jandorf, L.; Valdimarsdottir, H.B. BRCA genetic counseling among at-risk Latinas in New York City: New beliefs shape new generation. J. Genet. Couns. 2015, 24, 134–148. [Google Scholar] [CrossRef] [PubMed]
- Rajpal, N.; Muñoz, J.; Peshkin, B.N.; Graves, K.D. Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors. J. Genet. Couns. 2017, 26, 1221–1237. [Google Scholar] [CrossRef] [PubMed]
- Vadaparampil, S.T.; McIntyre, J.; Quinn, G.P. Awareness, Perceptions, and Provider Recommendation Related to Genetic Testing for Hereditary Breast Cancer Risk among At-Risk Hispanic Women: Similarities and Variations by Sub-Ethnicity. J. Genet. Couns. 2010, 19, 618–629. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Graves, K.D.; Jandorf, L.; Hurtado-de-Mendoza, A.; Peshkin, B.; Lynce, F.; Schwartz, M.; Quinn, G.P.; Pal, T.; Moreno, L.; Lopez, K.; et al. Programa de ÁRBOLES Familiares: An Innovative Training Program for Community Outreach and Educational Professionals to Assess Risk of Hereditary Breast and Ovarian Cancer in Latinas. In Proceedings of the Advancing the Science of Cancer in Latinos, San Antonio, TX, USA, 21–23 February 2018. [Google Scholar]
- Katz, S.J.; Ward, K.C.; Hamilton, A.S.; Mcleod, M.C.; Wallner, L.P.; Morrow, M.; Jagsi, R.; Hawley, S.T.; Kurian, A.W. Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer. J. Clin. Oncol. 2018, 36, 1218. [Google Scholar] [CrossRef] [PubMed]
- Benusiglio, P.R.; Di Maria, M.; Dorling, L.; Jouinot, A.; Poli, A.; Villebasse, S.; Le Mentec, M.; Claret, B.; Boinon, D.; Caron, O. Hereditary breast and ovarian cancer: Successful systematic implementation of a group approach to genetic counselling. Fam. Cancer 2017, 16, 51–56. [Google Scholar] [CrossRef] [PubMed]
- Roat, C.E.; Joseph, G.; Guerra, C.; Cheng, J.; Lee, R.; Lara-Otero, K. Interpreting for Cancer Genetics; California Healthcare Interpreting Association: Sacramento, CA, USA, 2016. [Google Scholar]
- Mittman, I.S.; Sullivan, L.W. Forming State Collaborations to Diversify the Nation’s Health Workforce: The Experience of the Sullivan Alliance to Transform the Health Professions. J. Genet. Couns. 2011, 20, 547–555. [Google Scholar] [CrossRef] [PubMed]
- Hurtado-de-Mendoza, A.; Gómez-Trillos, S.; Schwartz, M.; Peshkin, B.; Hamilton, H.; Fiallos, K.; Lynce, F.; Vadaparmpil, S.T.; Sheppard, V.B.; Adams-Campbell, L.; et al. Developing a Culturally Adapted Telephone Genetic Counseling Intervention for Latina Women at Risk of Hereditary Breast and Ovarian Cancer. In Proceedings of the Translational Science, Washington, DC, USA, 19–21 April 2018. [Google Scholar]
- Browner, C.H.; Mabel Preloran, H.; Casado, M.C.; Bass, H.N.; Walker, A.P. Genetic counseling gone awry: Miscommunication between prenatal genetic service providers and Mexican-origin clients. Soc. Sci. Med. 2003, 56, 1933–1946. [Google Scholar] [CrossRef]
- Penchaszadeh, V.B. Genetic Counseling Issues in Latinos. Genet. Test. 2001, 5, 193–200. [Google Scholar] [CrossRef] [PubMed]
- Benkendorf, J.L.; Prince, M.B.; Rose, M.A.; Fina, A.D.; Hamilton, H.E. Does indirect speech promote nondirective genetic counseling? Results of a sociolinguistic investigation. Am. J. Med. Genet. 2001, 106, 199–207. [Google Scholar] [CrossRef] [PubMed]
- Warren, N.S. Introduction to the Special Issue: Toward Diversity and Cultural Competence in Genetic Counseling. J. Genet. Couns. 2011, 20, 543–546. [Google Scholar] [CrossRef] [PubMed]
- Warren, N.S. The Genetic Counseling Cultural Competency Toolkit. 2010. Available online: http://www.geneticcounselingtoolkit.com/ (accessed on 17 June 2018).
- Bodurtha, J.N.; McClish, D.; Gyure, M.; Corona, R.; Krist, A.H.; Rodríguez, V.M.; Maibauer, A.M.; Borzelleca, J., Jr.; Bowen, D.J.; Quillin, J.M. The KinFact intervention—A randomized controlled trial to increase family communication about cancer history. J. Women’s Health 2014, 23, 806–816. [Google Scholar] [CrossRef] [PubMed]
- Fehniger, J.; Lin, F.; Beattie, M.S.; Joseph, G.; Kaplan, C. Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers. J. Genet. Couns. 2013, 22, 603–612. [Google Scholar] [CrossRef] [PubMed]
- Goss, P.E.; Lee, B.L.; Badovinac-Crnjevic, T.; Strasser-Weippl, K.; Chavarri-Guerra, Y.; St Louis, J.; Villarreal-Garza, C.; Unger-Saldaña, K.; Ferreyra, M.; Debiasi, M.; et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013, 14, 391–436. [Google Scholar] [CrossRef]
- Waldinger, R. Between Here and There: How Attached Are Latino Immigrants to Their Native Country? Available online: http://www.pewhispanic.org/2007/10/25/between-here-and-there-how-attached-are-latino-immigrants-to-their-native-country/ (accessed on 26 June 2018).
- Graves, K.D.; Christopher, J.; Harrison, T.M.; Peshkin, B.N.; Isaacs, C.; Sheppard, V.B. Providers’ Perceptions and Practices Regarding BRCA1/2 Genetic Counseling and Testing in African American Women. J. Genet. Couns. 2011, 20, 674–689. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Facilitators | Family |
---|---|
“I think that time and time again if you are thinking about Latina women specifically, their family has to be a big motivator. Common questions are: what is up with my daughter?” (Genetic counselor) “When they are doing the testing they are looking at a different perspective of being able to provide that new information for their family, so that the legacy of cancer does not continue in their family” (Genetic counselor) | |
Inform Treatment/Prevention Decisions | |
“Specifically women with ovarian cancer, it could help if they have a BRCA mutation, it could help with treatment options because there is a specific chemotherapy drug called “lemprasa”.” (Genetic counselor) “We know what caused the cancer, we can test another family member so that we can test: are they actually at risk for the same thing? And if they are, we are going to start taking care of them differently.” (Genetic counselor) | |
Doctors’ Recommendations | |
“Culturally, they tend to follow what the doctor is recommending” (Navigator) “What the doctors are telling them is what they should do. And they want to do everything that they can and they can make sure that they are very grateful (…) following up on whatever is recommended by them” (Genetic counselor) | |
Barriers | Cost and Insurance |
“I think the biggest barrier is getting them to take the test when they don’t have financial resources” (Navigator) “Finances are probably, potentially a barrier or a perceived barrier… Usually, nine times out of ten, we can find some way (to cover the test), whether it is going to a laboratory or coding it in the right way. We are at a level where people don’t have to pay anything for something that they can’t afford… In my experience, finances are becoming less of a barrier” (Genetic counselor) | |
Referrals | |
“Sometimes we have had some insured patients that have gone through counseling. But without insurance? It is out of the question. There is no mention of it… If there is a patient without insurance we can’t even give them the opportunity to talk about it, to explain about it” (Navigator) “We see very few Latinas referred to genetic counseling. I think they don’t know that they need to do it, maybe their doctors do not refer them or they don’t discuss about relatives with cancer. It is important to explain that if they have cancer in the family, they should talk with their doctor” (Geneticist) | |
Awareness, Education, and Language | |
“I think the bigger part of the barrier is that educational materials are not available in Spanish” (Navigator/social worker) “Lack of knowledge that these services exist, there is not a lot of promotion” (Navigator) | |
Logistic Barriers | |
“They don’t want to spend a ton of time going through things.” (Genetic counselor) “We have found that having people travel, even if we pay for travel, was a big barrier to service.” (Genetic counselor) | |
Emotions | |
“Removing that sense of fault. I see a lot of women who say “I cannot tell my family that this is going on” (…) “I can’t put this on them” like it is a burden they are putting on them” (Genetic counselor) “A lot of fear, fear of the results, of what the results will be, what will happen, so they don’t want to know if they are going to get cancer or not (…) fear of the costs” (MD, geneticist) | |
Spirituality | |
“I hear a lot of patients say you know it’s not the doctor, the doctors they can say what they want to say but it’s not them who have the last words, it’s God who has the last word with this.” (Psychology/counselor) | |
Fatalistic Beliefs | |
“I am not in control of the situation, so me doing a test is not going to make a difference” (Genetic counselor) “Whatever is going to happen, whatever God has in mind for me is what is going to happen. So, this idea that the information won’t necessarily change an outcome” (Genetic counselor) | |
Stigma | |
“I think there is stigma associated with it, especially back in those days, and especially in rural areas” (Navigator) “There was limited understanding about the causes of cancer (…) any disease that was considered contagious or that diminished the abilities in a family brought shame to the family ‘my family is unhealthy’” (Genetic counselor) | |
Systemic Barriers | |
“It is not only the obligations as a caretaker but also as the person who supports economically the family” (Psychologist). |
Family History |
“I’ve seen mainly women from El Salvador (…) someone had cancer and they didn’t know what type. Or it would be vague like, “they had cancer in their womb” but does that mean they had uterine cancer? Was that cervical cancer-was that ovarian cancer? It’s hard to know.” (Genetic counselor) “I’d say they know a little less about the family history. And they will communicate why. They’d say you know “with my family members it’s about culture: we don’t talk about illness,” or “when people died in my country, they just died. No one really talked about it much” or “a lot of people didn’t go to the doctor.” So on our family trees we have a lot of question marks regarding what could be the causes of death for people. Or occasionally it’s just cancer and we don’t have more specifics, which makes it hard to give a patient an accurate risk assessment.” (Genetic counselor) |
Communication with Relatives |
“That has been my biggest challenge. I have a few families where they have relatives coming afterward to be tested by me. So I don’t know how many of them are getting tested or who they end up communicating their test results to.” (Genetic counselor) “They don’t want to worry their family, so they haven’t told their families, their moms who live in a different country or they haven’t told their children or whatever it is. And I think that creates a lot a huge burden to keep that to yourself” (Genetic counselor) |
Testing Relatives Outside the US |
“I think that’s another thing that comes up a lot. They tell me, “that’s great that you tell me this information and that they need to do this testing or screening, but they don’t have access to it (…) so is it fair for me to do this testing and be like ‘good luck everyone else’?” (Genetic counselor) “So, we have a research registry with collaborating sites in Mexico and in Colombia and in Brazil (…) And sometimes those options are still very limited, especially when they live on the other side of the country. And so, it might not be feasible and then the other challenge, of course, is that if they test positive, they would not have access to those services that they will need.” (Genetic counselor) |
Language |
“Working through a translator is very difficult; the translation information isn’t really detailed and nuanced. So, it’s really a challenge for me to break down the information as much as I can to make sure that the patient is getting a good understanding of what we’re doing and why we’re doing it and that they’re able to make the same type of choice as someone who is an English speaker.” (Genetic counselor). “You take someone that doesn’t really have much health literacy or much anatomy, they are drawn into this world where people are throwing words at them (…) if it is in a language not even in your native language. And then you are trying to make decisions about these things when you can’t even grasp the most basic and what you even have. I imagine it is overwhelming.” (Genetic counselor) |
Emotions |
“Guilt, um blame, like you said if it’s they don’t have a good relationship with someone like their mother and then it turned out that it is maternally transmitted they blaming people who you don’t have a good relationship for this we’ve seen joy when you test negative which is almost I don’t wanna to say a full sense of security but having to kind of bring them down (…)” (Genetic counselor) “The parent is like ‘I didn’t even know that I had this (deleterious mutation). I’ve given it to my child and here my child is suffering because of something that I wasn’t even aware of.’ That’s where I see guilt the most I think. And then also too with young women who have been recently diagnosed and also have small children. It’s like, ‘not only am I sick,’ but there is this added pressure to like ‘taking care of my children but also now my children are at risk. I may not be there for them when they go through this too.” (Genetic counselor) |
Education and Misconceptions |
“Because one of them is the belief that all of us have cancer inside of us and it’s just waiting to be turned on and so this belief that everybody has cancer cells and those cancer cells are waiting to be activated (…) (Genetic counselor) “Gynecologic cancers can often be misreported, so while they say it’s ovarian, it was really uterus or cervical cancer (…) within Latinas and Spanish specifically (…) that is a common misunderstanding overall because some of the words they use interchangeably to describe female cancers.” (Genetic counselor) |
Engagement in Decision-Making (Respect) |
“When someone has a BRCA1 mutation, I would want them to have their ovaries removed too, but I want them to want to have their ovaries removed, to really understand why. And I think that their idea of what they look at as elective surgery is a hard thing to consider.” (Genetic counselor) “I like women to be engaged in discussing that and choosing what’s best for them, and what feels most comfortable. And I feel like maybe with the Latina women I see, it’s whatever I recommend” (Genetic counselor) |
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hurtado-de-Mendoza, A.; Graves, K.; Gómez-Trillos, S.; Anderson, L.; Campos, C.; Evans, C.; Stearns, S.; Zhu, Q.; Gonzalez, N.; Sheppard, V.B. Provider’s Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer. Healthcare 2018, 6, 116. https://doi.org/10.3390/healthcare6030116
Hurtado-de-Mendoza A, Graves K, Gómez-Trillos S, Anderson L, Campos C, Evans C, Stearns S, Zhu Q, Gonzalez N, Sheppard VB. Provider’s Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer. Healthcare. 2018; 6(3):116. https://doi.org/10.3390/healthcare6030116
Chicago/Turabian StyleHurtado-de-Mendoza, Alejandra, Kristi Graves, Sara Gómez-Trillos, Lyndsay Anderson, Claudia Campos, Chalanda Evans, Selma Stearns, Qi Zhu, Nathaly Gonzalez, and Vanessa B. Sheppard. 2018. "Provider’s Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer" Healthcare 6, no. 3: 116. https://doi.org/10.3390/healthcare6030116
APA StyleHurtado-de-Mendoza, A., Graves, K., Gómez-Trillos, S., Anderson, L., Campos, C., Evans, C., Stearns, S., Zhu, Q., Gonzalez, N., & Sheppard, V. B. (2018). Provider’s Perceptions of Barriers and Facilitators for Latinas to Participate in Genetic Cancer Risk Assessment for Hereditary Breast and Ovarian Cancer. Healthcare, 6(3), 116. https://doi.org/10.3390/healthcare6030116